How to Succeed in the Pharma Industry: Conversations with Instructors at MMS Academy Part 1

Part 1: Medical Writing and Pharmacovigilance

We sat down with the instructors for MMS Academy, MMS’ learning arm, for some advice on how to be successful to help those looking to work in the pharma industry.

In this first article, we talked with our instructors for medical writing and pharmacovigilance. Part 2 will highlight advice from our statistical programming and quality and compliance instructors.

Succeeding as a Medical Writer

Teresa Cesena, Director of Regulatory and Medical Writing, has over 10 years of pharmaceutical writing experience, and now leads the medical writing department. Her advice to students interested in entering the field of medical writing is:

  • Earn a degree in STEM
  • Grammar counts
  • Seek mentorship
  • Be ambitious

Amanda Beaster, Senior Manager of Regulatory Strategy, has over 10 years of experience in scientific writing for the research and pharmaceutical industries. She shares some advice below.

A successful career in medical writing can open up a world of opportunity to scientists seeking to be a part of the development of life-changing therapies that positively improve lives worldwide.” 

Tejaswini Ravindranath, Senior Medical Writer, has over 7 years of experience medical writing in the scientific research and pharmaceutical industries. She shares her advice for future medical writers in an acrostic poem below.

“Medical writing is one of the most dynamic branches of clinical research. My advice to anyone who wishes to pursue a career in medical writing is to follow the mantra ‘Go Data.’

G: Great quality

O: Ownership

D: Data Driven

A: Attention to Detail

T: Team Player

A: Ability to present data in a succinct manner

Amina Wofford, Medical Writer with over 10 years of scientific writing experience. Her advice is

“Medical writing is a career field with tremendous growth opportunities. If interested in pursuing a career in medical writing, there are two key steps to help start your career.”

  • Have a background in STEM
  • Be willing to learn!

Succeeding in Pharmacovigilance

Arunima Sen, Director of Pharmacovigilance and Medical Writing, has more than 14 years of experience in medical affairs and drug safety. She has 3 tips for a successful career in pharmacovigilance.

  • Be passionate about safeguarding patients’ interest in the life cycle of a drug
  • Get the basic understanding of drug development and regulatory landscape right
  • Being tech-savvy helps 

Pallavi Dua, Senior Manager of Pharmacovigilance has over 14 years of experience in the healthcare and pharmacovigilance domains. She shares what it has been like for those working in pharmacovigilance during the COVID-19 pandemic.

“In 2020, when the COVID-19 pandemic hit the world, we at MMS worked hand in hand with Pharma organizations to ensure the timely and seamless launch of vaccines. Come be a part of an industry that directly makes a difference to the lives of people globally through cutting edge pharmacovigilance, which keeps the world safe and ready for any future health emergencies.”

Sign up for courses here.

Suggested For You

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives

July 9th, 2024

Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line

perspectives

July 2nd, 2024

Part 1: RWD Noninterventional Study Design and FDA Engagement Opportunity for Early Stage Oncology

perspectives

June 21st, 2024

Peer-Reviewed Journal Articles: The Crucial Role of Publication in the Pharmaceutical Industry

perspectives

June 14th, 2024

A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry

perspectives

June 6th, 2024

Datacise and Diversity in Patient Enrollment: Combining Geospatial and Demographic Data to Aid Site Selection

perspectives

May 29th, 2024

Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules

perspectives

May 21st, 2024

Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of “Nonmedical Use” On Labelling

perspectives

May 10th, 2024

Psychedelics in Drug Development and Regulatory Considerations Part I: Benefit-Risk

perspectives

April 29th, 2024

Validation of Clinical Dashboards for Decision Making